Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Open in API
Filings indexed 1,031 across all filing types
Latest filing 2022-10-28 Declaration of Voting R…
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
OXUR PR_Voting rights (NED)_20221026.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled 'Gereglementeerde informatie - Noemer' (Regulated information - Denominator) and explicitly states it is providing information regarding the 'Totaal Aantal Stemrechten' (Total Number of Voting Rights) following a conversion event. It details the issuance of new shares due to the conversion of convertible bonds and calculates the new total number of outstanding shares (the denominator) as required by disclosure regulations (referencing Article 15 of the Belgian law of May 2, 2007). This type of mandatory disclosure, focusing on the total share count used for ownership percentage calculations, is a specific type of regulatory announcement. Since it is a formal, mandatory disclosure about capital structure changes impacting voting rights, it fits best under the general 'Regulatory Filings' (RNS) category, as it is not a full financial report (10-K, IR), an earnings release (ER), or a specific management/board change announcement (MANG). It is a specific regulatory update on share capital/voting rights, which often falls under RNS if a more specific code like SHA (Share Issue/Capital Change) isn't perfectly applicable, although SHA is close. However, the core purpose here is the mandatory disclosure of the *denominator* for ownership calculations, which is a common regulatory filing requirement. Given the options, RNS is the most appropriate general regulatory filing category for this specific type of mandatory notification that isn't a standard financial report or a simple dividend/insider trade notice. The document length (8519 chars) is substantial, ruling out RPA based on the 'MENU VS MEAL' rule, as this is the substance of the filing, not just an announcement of an attachment.
2022-10-28 Dutch
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA" and explicitly states the resulting total number of shares carrying voting rights (the denominator) after capital increases due to convertible bond conversions. This type of mandatory disclosure, which updates the total share count used for calculating ownership percentages, is a specific regulatory requirement often related to major shareholding notifications or capital structure changes. While it involves capital changes (CAP) and major shareholding thresholds (MRQ), the core purpose is announcing the updated denominator as required by Belgian law (Article 15 of the Act of May 2, 2007). Since the document is a formal announcement detailing the change in the total number of voting rights, it most closely aligns with a notification regarding capital structure or a major shareholding update. Given the focus on the total number of voting rights and the context of capital conversion, it fits best under Capital/Financing Update (CAP) or Major Shareholding Notification (MRQ). However, the primary function here is updating the official count of voting rights, which is a prerequisite for major shareholding reports but is also a direct consequence of a financing/capital event. Since the document details the issuance of new shares and the resulting total share count, 'CAP' (Capital/Financing Update) is a strong candidate, but 'MRQ' (Major Shareholding Notification) is often used for denominator updates. Looking at the definitions, 'MRQ' is for changes in significant share ownership levels, which this denominator update facilitates. However, the document is fundamentally about the change in the total number of shares issued. Since the text explicitly details the capital increase resulting from bond conversion and provides the new total share count, 'CAP' is highly relevant. If a more specific 'Voting Rights Update' category existed, it would be chosen. Between the available options, this is a direct consequence of financing activity (bond conversion) and directly impacts shareholding calculations. I will classify this as a Capital/Financing Update (CAP) because the trigger is the conversion of convertible bonds leading to a capital increase, and the denominator update is the result. Alternatively, since it is a mandatory disclosure of the denominator, it is often grouped with major shareholding disclosures. Given the explicit mention of the capital increase and the focus on the total number of securities, CAP is slightly more accurate than MRQ, which focuses on *who* owns the shares crossing thresholds. I will lean towards CAP due to the explicit financial transaction described, but acknowledge the strong link to MRQ. Let's re-evaluate: The title is about the Denominator. Denominator updates are crucial for MRQ filings. Since the document is a formal, required disclosure about the total voting rights count, it functions as a regulatory update tied to share structure. I will select MRQ as it directly relates to the mechanism used for tracking major shareholdings, which is the denominator. If MRQ is too narrow, RNS is the fallback. Given the specificity of the content (voting rights denominator update), MRQ seems the most appropriate fit among the choices related to share structure changes, even if the trigger was financing. I will choose MRQ as the most specific fit for a denominator disclosure.
2022-09-30 English
OXUR PR_Voting rights (NED)_20220930.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled 'Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op NEGMA Conversie-Notificatie' and explicitly references Article 15 of the Belgian law regarding the disclosure of major shareholdings. It details the change in the total number of outstanding voting shares (the 'noemer' or denominator) following a capital increase via convertible bond conversion. This type of mandatory disclosure, focusing on the total number of shares for ownership percentage calculations, strongly aligns with regulations concerning major shareholdings or capital structure changes that affect voting rights. While it involves capital changes (CAP) and share issuance (SHA), the primary focus and regulatory context provided (disclosure of the total share count/denominator) is most closely related to notifications about significant share ownership thresholds or capital structure changes impacting voting rights. Given the options, 'Major Shareholding Notification' (MRQ) is the closest fit for a mandatory disclosure announcing the new total share count used as a denominator for ownership calculations, although 'Share Issue/Capital Change' (SHA) is also relevant. However, since the text is a formal press release announcing the updated total number of voting rights/shares (the denominator) as required by law (Article 15), it functions as a notification related to the capital structure impacting ownership reporting. In many jurisdictions, these specific denominator updates are often bundled with major shareholding disclosures or treated as specific regulatory filings. Given the explicit focus on the 'Noemer' (denominator) following a capital event, and the reference to disclosure laws, 'Major Shareholding Notification' (MRQ) is a strong candidate, but 'Share Issue/Capital Change' (SHA) directly addresses the underlying event (conversion leading to capital increase). Since the document is a formal press release detailing the resulting share count, and not just a brief announcement of a report, it is not RPA. Considering the core content is the calculation of the total number of shares outstanding (the denominator), which is crucial for Major Shareholding Notifications (MRQ), I will select MRQ as the most specific fit for this type of regulatory disclosure, even though it stems from a capital event.
2022-09-30 Dutch
OXUR GLOBAL - Financial report 30-06-2022 (EN) FINAL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Financial Report' and covers the half-year results as of June 30, 2022. It contains detailed unaudited consolidated financial statements, including the statement of financial position and the statement of profit and loss, along with management commentary on business operations, pipeline updates, and corporate activities. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2022-09-07 English
OXUR GLOBAL - Financial report 30-06-2022 (NL) FINAL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Tussentijds Financieel Verslag' (Interim Financial Report) for the period ending June 30, 2022. It contains comprehensive financial statements, including a consolidated balance sheet and income statement, as well as detailed management commentary on business activities, clinical trial status, and corporate developments. It is not a mere announcement or certification, but the substantive interim report itself. H1 2022
2022-09-07 Dutch
Oxurion Announces Amendment to Funding Program with Negma Group for EUR 6 Million in Funding.pdf
Capital/Financing Update Classification · 98% confidence The document is a press release dated September 2, 2022, announcing an amendment to a funding program with Negma Group, detailing the terms of accessing EUR 6 million in cash tranches and referencing ongoing clinical trials (KALAHARI Phase 2). This content—announcing a specific financing agreement, capital structure adjustment, and providing operational updates—aligns best with the 'Capital/Financing Update' category. It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), but a specific corporate action announcement related to financing.
2022-09-02 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.